GDUFA III Talks Completed

Fees will Fund Inspection, Complex Generic Improvements

 
• By Derrick Gingery
  
Agreement reached
GDUFA III was the last of three FDA human drug and biologic user fee renewal agreements to be completed • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Generics

More from Products